Sohn Catherine A. 4
4 · Altimmune, Inc. · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Sohn Catherine A.
Director
Transactions
- Award
Stock Options (option to buy)
2025-02-06+18,600→ 18,600 totalExercise: $6.91Exp: 2035-02-06→ Common Stock, par value $0.0001 (18,600 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest as follows: (i) 50% on July 15, 2025, (ii) 25% on September 30, 2025 and 25% on December 31, 2025, subject to the reporting person's continued service through the applicable vesting date.